Biotech1 year ago
ADmit Therapeutics Closes a Round of €5.4 Million for Its Technology Against Alzheimer’s
Admit Therapeutics is developing a test that uses sequencing and a machine learning approach to measure methylation changes in mitochondrial DNA that can predict progression towards...